Literature DB >> 19210353

Strontium ranelate-induced DRESS syndrome: first two case reports.

A P Jonville-Béra1, B Crickx, L Aaron, I Hartingh, E Autret-Leca.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19210353     DOI： 10.1111/j.1398-9995.2009.01940.x

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  8 in total

Review 1.  Screening, diagnosis and treatment of osteoporosis: a brief review.

Authors:  Roberto Bernabei; Anna Maria Martone; Elena Ortolani; Francesco Landi; Emanuele Marzetti
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

2.  Cutaneous side effects of antiosteoporosis treatments.

Authors:  Philippe Musette; Jean-Marc Kaufman; René Rizzoli; Patrice Cacoub; Maria Louisa Brandi; Jean-Yves Reginster
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-02       Impact factor: 5.346

Review 3.  Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.

Authors:  Rebecca Pavlos; Simon Mallal; David Ostrov; Yuri Pompeu; Elizabeth Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2014 Jan-Feb

4.  The cost-effectiveness of strontium ranelate in the UK for the management of osteoporosis.

Authors:  F Borgström; O Ström; J Coelho; H Johansson; A Oden; E McCloskey; J A Kanis
Journal:  Osteoporos Int       Date:  2009-06-10       Impact factor: 4.507

Review 5.  Eosinophilic Drug Allergy.

Authors:  Merin Kuruvilla; David A Khan
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 10.817

6.  Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications.

Authors:  J-J Body; P Bergmann; S Boonen; J-P Devogelaer; E Gielen; S Goemaere; J-M Kaufman; S Rozenberg; J-Y Reginster
Journal:  Osteoporos Int       Date:  2012-02-04       Impact factor: 4.507

Review 7.  Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity.

Authors:  P Musette; M L Brandi; P Cacoub; J M Kaufman; R Rizzoli; J-Y Reginster
Journal:  Osteoporos Int       Date:  2009-11-17       Impact factor: 5.071

8.  Drug rash with eosinophilia and systemic symptoms (DRESS) in patients receiving strontium ranelate.

Authors:  P Cacoub; V Descamps; O Meyer; C Speirs; P Belissa-Mathiot; P Musette
Journal:  Osteoporos Int       Date:  2013-01-30       Impact factor: 5.071
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.